Related Experiment Video
Updated: Aug 16, 2026

08:28
Experimental Models for Study of Retinal Pigment Epithelial Physiology and Pathophysiology
Published on: November 6, 2010
Pathophysiologic effect of interleukin-1b in the rabbit retina
J A Martiney1, M Litwak, J W Berman
1Department of Pathology, Albert Einstein College of Medicine, Bronx, New York 10461.
The American Journal of Pathology
|December 1, 1990
Summary
Interleukin-1 beta (IL-1b) triggers central nervous system inflammation in rabbit retinas, causing visual evoked potential alterations and blood-brain barrier changes. This study establishes the rabbit retina as a model for analyzing CNS inflammation.
Area of Science:
- Neuroscience
- Immunology
- Ophthalmology
Background:
- Interleukin-1 (IL-1) is a key immunomodulator initiating inflammatory responses.
- Understanding IL-1 effects in the central nervous system (CNS) is crucial for neuroinflammation research.
Purpose of the Study:
- To investigate the effects of Interleukin-1 beta (IL-1b) in the CNS using the rabbit retina as a model.
- To correlate electrophysiological changes with pathological inflammatory events.
Main Methods:
- Intravitreal injection of IL-1b into rabbit eyes.
- Monitoring of visual evoked potentials (VEP) and optic tract responses.
- Histological analysis of retinal tissues and inflammatory cell infiltration.
- Assessment of blood-brain barrier permeability.
Main Results:
- IL-1b injection caused significant VEP alterations, correlating with inflammation.
- Intravascular red blood cell accumulation, hemorrhage, and cellular inflammation were observed.
- Mononuclear and polymorphonuclear cell infiltration peaked at 24 hours post-injection.
- Changes in blood-brain barrier permeability and gliosis were noted.
Conclusions:
- The rabbit retina serves as a valuable in vivo model for studying CNS inflammation.
- IL-1b induces a robust inflammatory response in the retina with measurable physiological and pathological consequences.
- Antibody neutralization demonstrated the specificity of IL-1b's inflammatory effects.

